TY - JOUR
T1 - Optimizing pharmacotherapy and deprescribing strategies in older adults living with multimorbidity and polypharmacy
T2 - EuGMS SIG on pharmacology position paper
AU - van Poelgeest, Eveline
AU - Seppala, Lotta
AU - Bahat, G. listan
AU - Ilhan, Birkan
AU - Mair, Alpana
AU - van Marum, Rob
AU - Onder, Graziano
AU - Ryg, Jesper
AU - Fernandes, Marília Andreia
AU - Cherubini, Antonio
AU - Denkinger, Michael
AU - Eidam, Annette
AU - Egberts, Angelique
AU - Gudmundsson, A. alsteinn
AU - Koçak, Fatma Özge Kayhan
AU - Soulis, George
AU - Tournoy, Jos
AU - Masud, Tahir
AU - Wehling, Martin
AU - van der Velde, Nathalie
N1 - Funding Information: No funds, grants, or other support was received for this project. Publisher Copyright: © 2023, The Author(s).
PY - 2023/12
Y1 - 2023/12
N2 - Inappropriate polypharmacy is highly prevalent among older adults and presents a significant healthcare concern. Conducting medication reviews and implementing deprescribing strategies in multimorbid older adults with polypharmacy are an inherently complex and challenging task. Recognizing this, the Special Interest Group on Pharmacology of the European Geriatric Medicine Society has compiled evidence on medication review and deprescribing in older adults and has formulated recommendations to enhance appropriate prescribing practices. The current evidence supports the need for a comprehensive and widespread transformation in education, guidelines, research, advocacy, and policy to improve the management of polypharmacy in older individuals. Furthermore, incorporating deprescribing as a routine aspect of care for the ageing population is crucial. We emphasize the importance of involving geriatricians and experts in geriatric pharmacology in driving, and actively participating in this transformative process. By doing so, we can work towards achieving optimal medication use and enhancing the well-being of older adults in the generations to come.
AB - Inappropriate polypharmacy is highly prevalent among older adults and presents a significant healthcare concern. Conducting medication reviews and implementing deprescribing strategies in multimorbid older adults with polypharmacy are an inherently complex and challenging task. Recognizing this, the Special Interest Group on Pharmacology of the European Geriatric Medicine Society has compiled evidence on medication review and deprescribing in older adults and has formulated recommendations to enhance appropriate prescribing practices. The current evidence supports the need for a comprehensive and widespread transformation in education, guidelines, research, advocacy, and policy to improve the management of polypharmacy in older individuals. Furthermore, incorporating deprescribing as a routine aspect of care for the ageing population is crucial. We emphasize the importance of involving geriatricians and experts in geriatric pharmacology in driving, and actively participating in this transformative process. By doing so, we can work towards achieving optimal medication use and enhancing the well-being of older adults in the generations to come.
KW - Appropriate prescribing
KW - Deprescribing
KW - Multimorbidity
KW - Older adults
KW - Polypharmacy
UR - http://www.scopus.com/inward/record.url?scp=85173915591&partnerID=8YFLogxK
U2 - https://doi.org/10.1007/s41999-023-00872-0
DO - https://doi.org/10.1007/s41999-023-00872-0
M3 - Article
C2 - 37812379
SN - 1878-7649
VL - 14
SP - 1195
EP - 1209
JO - European Geriatric Medicine
JF - European Geriatric Medicine
IS - 6
ER -